In breast cancer, SOX1 is activated due to the loss of miR-335, which was also found down-regulated in our study (Table 1) suggesting that miR-129 might also play a role in the SOX1 mediated acquisition of metastatic capacity [12], [15]. The gene discussed is SOX1; the disease is breast cancer.